Cerebral angiography is a minimally invasive medical imaging technique used to visualize the blood vessels in brain and neck. It helps detect aneurysms, arterial vascular malformations, strokes, tumors and other conditions. Cerebral angiography provides real-time visualization of arteries allowing physicians to evaluate abnormalities and blockages. The global cerebral angiography market is estimated to be valued at US$ 14.96 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Rising preference for minimally-invasive procedures has accelerated growth of Global Cerebral Angiography Market Size Cerebral angiography is considered as gold standard for diagnosis of various brain-related conditions with advantages such as less complications, shorter hospital stay and quicker recovery compared to open surgeries. With increasing awareness about benefits of minimally-invasive techniques among patients and physicians, demand for cerebral angiography is growing significantly. Manufacturers are focusing on developing advanced cerebral angiography devices and software with improved accuracy and safety features to further drive the adoption of these procedures.
Segment Analysis
The global cerebral angiography market is dominated by catheter angiography sub-segment and is expected to continue dominating the market during the forecast period. Catheter angiography is considered as a gold standard for diagnosing cerebrovascular disorders and is widely used by healthcare providers globally. The procedure provides high quality images of blood vessels without affecting the surrounding brain tissue leading to its increased preference among physicians.
Key Takeaways
The global cerebral angiography market is expected to witness high growth during the forecast period. Advancements in technology are supporting the growth of less invasive angiography procedures like CT angiography and MRI angiography. However, catheter angiography continues to be the mainstream procedure for its ability to offer live images of cerebral arteries.
Regional analysis
North America is currently the dominant region in the global cerebral angiography market owing to high prevalence of cerebrovascular diseases and availability of advanced healthcare facilities. However, Asia Pacific is expected to grow at the fastest pace during the forecast period supported by rising healthcare expenditure, improving access to healthcare and changing lifestyle habits in the region.
Key players
Key players operating in the cerebral angiography market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Hitachi, Ltd., Carestream Health, Inc., Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, AngioDynamics, Inc., Penumbra, Inc., MicroPort Scientific Corporation, Cook Medical LLC. Siemens Healthineers and GE Healthcare currently lead the global market owing to their robust product portfolios and strong geographical presence across major markets.
Get More Insights On This Topic: https://www.newsstatix.com/cerebral-angiography-market-size-share-analysis-2023-2030/
The Global Minimally-Invasive Cosmetic Procedures Market is growing pervasively mainly due to the augmenting demand for procedures such as microdermabrasion, laser hair removal, and others.
The Minimally-Invasive Cosmetic Procedures Market is increasing the uptake of these procedures.
Moreover, increasing expenditure on overall cosmetic procedures such as botulinum toxins, soft tissue fillers, and adipose tissue regeneration are escalating the market on global heights.Acknowledging the ascending graph of the growth, the market is climbing steadily, Market Research Future (MRFR), in its recently published study report foretells that the global minimally-invasive cosmetic procedures market will register over 6.1% CAGR from 2017 to 2023, increasing by 2023.
The market is booming and estimated to garner further prominence over the anticipated period.Request Free Sample Report at:https://www.marketresearchfuture.com/sample_request/5923 Market SegmentsBy Procedures: Botulinum Toxins, Soft Tissue Fillers, Chemical Peel, Laser Hair Removal, and Microdermabrasion among others.By Products: Microdermabrasion Products (microdermabrasion tips, microdermabrasion crystals, microdermabrasion creams and scrubs, and others.
), Hair Removal Laser, and Botulinum Toxins among others.By Application: Acne & Trauma Scars, Hyperpigmentation, and Adipose Tissue Regeneration among others.By End-users: Hospitals, Dermatology Clinics, and Home Care, among others.By Regions: Europe, North America, APAC and the Rest-of-the-World.The minimally-invasive cosmetic procedures market appears highly competitive and fragmented characterized by several large-scale players having a regional and international presence.
Well-established players incorporate acquisition, collaboration, partnership, expansion, and technology launch in order to gain competitive advantage and to maintain their positions in this market.
